Stock ROVI LABORATORIOS FARMACEUTICOS ROVI, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Laboratorios Farmaceuticos Rovi, S.A.

Equities

ROVI

ES0157261019

Market Closed - BME
Other stock markets
 11:35:13 2024-05-21 am EDT 		After market 12:41:42 pm
88.2 EUR +0.46% Intraday chart for Laboratorios Farmaceuticos Rovi, S.A. 88.22 +0.03%
May. 08 Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LABORATORIOS FARMACEUTICOS ROVI, S.A. Stock Laboratorios Farmaceuticos Rovi, S.A.
 4.94B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 705B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 583B
JOHNSON & JOHNSON Stock Johnson & Johnson
 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
 332B
ABBVIE INC. Stock AbbVie Inc.
 291B
  1. Stock Market
  2. Equities
  3. ROVI Stock
  4. Charts Laboratorios Farmaceuticos Rovi, S.A.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW